Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Related Citations for PubMed (Select 19064828)

1.
2.

Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.

Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach S, Manns B, Bello A, James M, Turin TC, Tonelli M; Alberta Kidney Disease Network.

Arch Intern Med. 2011 Nov 28;171(21):1920-7. doi: 10.1001/archinternmed.2011.537.

PMID:
22123800
3.

Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Romero P, Salvat M, Fernández J, Baget M, Martinez I.

J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.

PMID:
17331857
4.

Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes.

Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, Astor BC, Sharrett AR, Brancati FL, Coresh J.

Diabetes. 2011 Jan;60(1):298-305. doi: 10.2337/db10-1198. Epub 2010 Oct 26.

5.

Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease.

Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ.

J Am Soc Nephrol. 2005 Nov;16(11):3411-7. Epub 2005 Oct 5.

6.

Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease.

Freedman BI, Shihabi ZK, Andries L, Cardona CY, Peacock TP, Byers JR, Russell GB, Stratta RJ, Bleyer AJ.

Am J Nephrol. 2010;31(5):375-9. doi: 10.1159/000287561. Epub 2010 Mar 19.

PMID:
20299782
7.

Intrapersonal HbA(1c) variability and the risk of progression of nephropathy in patients with Type 2 diabetes.

Rodríguez-Segade S, Rodríguez J, García López JM, Casanueva FF, Camiña F.

Diabet Med. 2012 Dec;29(12):1562-6. doi: 10.1111/j.1464-5491.2012.03767.x.

PMID:
22913483
8.

Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.

Selvin E, Rawlings AM, Grams M, Klein R, Sharrett AR, Steffes M, Coresh J.

Lancet Diabetes Endocrinol. 2014 Apr;2(4):279-88. doi: 10.1016/S2213-8587(13)70199-2. Epub 2014 Jan 15.

PMID:
24703046
9.

Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.

Zoppini G, Targher G, Chonchol M, Perrone F, Lippi G, Muggeo M.

Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):580-6. doi: 10.1016/j.numecd.2008.11.003. Epub 2009 Feb 3.

PMID:
19196499
10.

Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study.

Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW.

Arch Intern Med. 2005 Sep 12;165(16):1910-6.

PMID:
16157837
11.

Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study.

Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, Sharrett AR.

Lancet Neurol. 2005 Dec;4(12):821-6.

PMID:
16297840
12.

Glycated hemoglobin and risk of hypertension in the atherosclerosis risk in communities study.

Bower JK, Appel LJ, Matsushita K, Young JH, Alonso A, Brancati FL, Selvin E.

Diabetes Care. 2012 May;35(5):1031-7. doi: 10.2337/dc11-2248. Epub 2012 Mar 19.

13.

A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up.

Rius Riu F, Salinas Vert I, Lucas Martín A, Romero González R, Sanmartí Sala A.

J Diabetes Complications. 2003 Sep-Oct;17(5):235-42.

PMID:
12954150
14.

Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?

Sabanayagam C, Liew G, Tai ES, Shankar A, Lim SC, Subramaniam T, Wong TY.

Diabetologia. 2009 Jul;52(7):1279-89. doi: 10.1007/s00125-009-1360-5. Epub 2009 Apr 22.

PMID:
19387611
15.

Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.

Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC.

Am J Kidney Dis. 2009 Apr;53(4):596-605. doi: 10.1053/j.ajkd.2008.10.044. Epub 2008 Dec 24.

16.

HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.

Hsu CC, Chang HY, Huang MC, Hwang SJ, Yang YC, Lee YS, Shin SJ, Tai TY.

Diabetologia. 2012 Dec;55(12):3163-72. doi: 10.1007/s00125-012-2700-4. Epub 2012 Aug 26.

PMID:
22923064
18.

Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.

Nordwall M, Arnqvist HJ, Bojestig M, Ludvigsson J.

Pediatr Diabetes. 2009 May;10(3):168-76. doi: 10.1111/j.1399-5448.2008.00472.x. Epub 2008 Oct 22.

PMID:
19175900
19.

Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.

Bleyer AJ, Sedor JR, Freedman BI, O'Brien A, Russell GB, Graley J, Schelling JR.

Am J Kidney Dis. 2008 Jan;51(1):29-37.

PMID:
18155530
20.

The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes.

Olsen BS, Sjølie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB, Mortensen HB; Danish Study Group of Diabetes in Childhood.

J Diabetes Complications. 2004 May-Jun;18(3):160-4.

PMID:
15145327
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk